topical

Question 1

Erythema

Answer 1

redness of the skin

Question 2

Pruritis

Answer 2

a skin disorder attended with itching

Question 3

Candidiasis

Answer 3

a fungal infection

Question 4

Tinea

Answer 4

ringworm

Question 5

AA

Answer 5

Affected area

Question 6

Crm

Answer 6

Cream

Question 7

Ung

Answer 7

Ointment

Question 8

Cmpd

Answer 8

Compound

Question 9

UD

Answer 9

As directed

Question 10

PRN

Answer 10

As needed

Question 11

Lidocaine MOA

Answer 11

Local anesthetic agent

Stabilize neuronal membranes producing an analgesic effect

Question 12

Lidocaine indications

Answer 12

Treatment/relief of pain

Question 13

Lidocaine adverse effects

Answer 13

Application site irritation

Question 14

Lidocaine interactions

Answer 14

Antiarrhythmic agents

Local anesthetics

Question 15

Lidocaine counseling

Answer 15

Apply to intact skin only; patches may be cut into smaller sizes with scissors before removal of the release liner
Wash hands after handling patch and avoid eye contact
Store and dispose of patches out of the reach of children, pets, and others
Never reuse a patch
Remove patch prior to MRI procedures to avoid burns

Question 16

Clobetasol, Fluocinonide, Hydrocortisone, Mometasone, Triamcinolone
Topical Corticosteroids MOA

Answer 16

Produces anti-inflammatory, antipruritic, and vasoconstrictor actions

Question 17

Clobetasol, Fluocinonide, Hydrocortisone, Mometasone, Triamcinolone
Topical Corticosteroids indications

Answer 17

Psoriasis

Dermatitis

Question 18

Clobetasol, Fluocinonide, Hydrocortisone, Mometasone, Triamcinolone
Topical Corticosteroids adverse effects

Answer 18

Dryness
Burning
Itching
Irritation

Question 19

Clobetasol, Fluocinonide, Hydrocortisone, Mometasone, Triamcinolone
Topical Corticosteroids counseling

Answer 19

For external use only; do not apply to mucous membranes
Apply in a thin layer
Do not cover treated area unless directed by a physician
Avoid sunlight exposure to affected area

Question 20

Metronidazole, Mupirocin, Chlorhexidine, Clindamycin

Topical Antibiotics/Antiseptics MOA

Answer 20

Inhibits protein synthesis

Causes cell death in susceptible organisms

Question 21

Metronidazole, Mupirocin, Chlorhexidine, Clindamycin

Topical Antibiotics/Antiseptics indications

Answer 21

Treatment of acne/rosacea

Treatment of bacterial vaginosis

Question 22

Metronidazole, Mupirocin, Chlorhexidine, Clindamycin

Topical Antibiotics/Antiseptics adverse effects

Answer 22

Topical: Burning, skin irritation, dryness, headache
Vaginal: Vulva/vaginal irritation, vaginal discharge, fungal infection
Serious: leukopenia

Question 23

Metronidazole, Mupirocin, Chlorhexidine, Clindamycin

Topical Antibiotics/Antiseptics interactions

Answer 23

Warfarin?

Alcohol?

Question 24

Metronidazole, Mupirocin, Chlorhexidine, Clindamycin

Topical Antibiotics/Antiseptics patient counseling

Answer 24

For external use only
Avoid contact with eyes or mouth
Wash hands and affected areas before application of gel
Cosmetics can be worn after application of gel
Discontinue use and notify physician if skin rash occurs
Vaginal Product:

Question 25

Mupirocin MOA

Answer 25

Inhibits protein synthesis in susceptible organisms

Question 26

Mupirocin indications

Answer 26

Secondary infected skin lesions Impetigo Elimination of nasal MRSA

Question 27

Mupirocin adverse effects

Answer 27

Burning Stinging Erythema

Question 28

Mupirocin counseling

Answer 28

For external use only Avoid contact with eyes or mouth. Treated area may be covered with a dressing Contact provider if no improvement is seen in 3-5 days

Question 29

Chlorhexidine MOA

Answer 29

Binds to bacterial cell walls and extramicrobial complexes | Bactericidal effect

Question 30

Chlorhexidine indications

Answer 30

Skin cleanser | Germicidal hand rinse

Question 31

Chlorhexidine adverse effects

Answer 31

Erythema Roughness and/or dryness Sensitization

Question 32

Chlorhexidine counseling

Answer 32

For external use only Do not swallow solution Do not apply to wounds that involve more than superficial layers of skin Do not use on lumbar puncture sites Solutions may be flammable Avoid application to hairy areas, which may significantly delay drying time

Question 33

Clindamycin MOA

Answer 33

Inhibit protein synthesis by binding to 50S ribosomal subunits The drug inhibits the growth of susceptible organisms on the surface of the skin and reduces the concentration of free fatty acids in sebum.

Question 34

Clindamycin indications

Answer 34

Treatment of acne Treatment of bacterial vaginosis Treatment of susceptible bacterial infections

Question 35

Clindamycin adverse effects

Answer 35

Topical: Dryness, burning, itching, scaliness/peeling skin, erythema, oiliness Vaginal: Vaginal candidiasis, vaginitis, pruritis, vaginal pain

Question 36

Clindamycin counseling

Answer 36

Patient Counseling (Topical) Wash hands thoroughly before and after applying Apply small amount of product to affected area Wait 30 minutes before shaving or applying makeup after application Patient Counseling (Vaginal) Remain lying down for 30 minutes following administration Avoid intercourse during therapy Vaginal products may weaken condoms or contraceptive diaphragms

Question 37

Ketoconazole, Terconazole

Answer 37

Topical Antifungals

Question 38

Ketoconazole, Terconazole MOA

Answer 38

Disrupts cell wall permeability

Question 39

Ketoconazole, Terconazole indications

Answer 39

Ketoconazole Treatment of cutaneous fungal infections Terconazole Treatment of uncomplicated vulvovaginal candidiasis

Question 40

Ketoconazole, Terconazole adverse effects

Answer 40

Ketoconazole Severe skin irritation, pruritis, stinging Terconazole Burning and irritation, itching

Question 41

Ketoconazole counseling

Answer 41

For external use only; not for ophthalmic, oral, or intravaginal use Although improvement and symptom relief usually occur quickly, continue to treat for recommended time period

Question 42

Terconazole counseling

Answer 42

For vaginal use only Refrain from intercourse during period of treatment - sexual partner may experience penile irritation Suppositories may cause breakdown of condoms and diaphragms - avoid concurrent use Finish course of therapy even if symptoms have improved Vaginal product does not appear to interact with oral contraceptives